NCI Cohort Consortium

Overview

The NCI Cohort Consortium is an extramural-intramural partnership formed by the National Cancer Institute (NCI) to address the need for large-scale collaborations to pool the large quantity of data and biospecimens necessary to conduct a wide range of cancer studies. Through its collaborative network of investigators, the Consortium provides a coordinated, interdisciplinary approach to tackling important scientific questions, economies of scale, and opportunities to quicken the pace of research.

Save the Date

Please SAVE THE DATE for the next NCI Cohort Consortium Annual Meeting: November 16-18, 2020, Bolger Center, Potomac, Maryland.

Featured Publication

The National Cancer Institute Cohort Consortium: An International Pooling Collaboration of 58 Cohorts from 20 Countries.

Read the Article

Featured Funding

This Notice of Special Interest informs current awardees that supplemental funding is available for facilitating collaboration, preparation, harmonization, pooling and analyses of data collected for steering committee approved scientific projects in the NCI Cohort Consortium.

View NOT-CA-20-030

Annual Meetings

The 2019 Cohort Consortium Annual Meeting was held November 18-20, 2019 at NCI's Shady Grove Campus in Rockville, MD. A summary of the meeting will be posted here in early 2020.

Please SAVE THE DATE for the NCI Cohort Consortium Annual Meeting, which will be held November 16-18, 2020.

View information about past meetings:

Advancing Collaborative Cancer Epidemiology Research

Figure: 60 Epidemiology Cohorts (36 in North America, 7 in Asia, 16 in Europe, and 1 in Australia; Two cohorts include study participants from both North America and Australia) with > 7 Million Participants (male, female, white, black, asian, hispanic); Biospecimens (inc. plasma/serum, saliva/buccal cells, urine, buffy coat/whole blood, tissues, and nails) have been collected on approx. 2 million individuals; Thousands of biospecimens for major cancer sites (inc. breast, prostate, lung, colon & rectum, melanoma, and bladder); Cohort Consortium members participate in approximately 50 projects which have made scientific discoveries about cancer risk factors and technical advances in cohort methodologies; For membership, Cohorts must have a min. of 10k study participants, cancer endpoints, and commitment to scientific collaborations through participating in pooling studies; To join or collaborate, contact Nonye Harvey, Dr.P.H., M.P.H., at NCICohortConsortium@mail.nih.gov.

Contact Us

For questions or any other information about the NCI Cohort Consortium, please contact us.